ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012